產(chǎn)品描述: | Remodelin, a specific inhibitor of N-acetyltransferase NAT10, can ameliorate Hutchinson-Gilford Progeria Syndrom (HGPS) cellular phenotypes. Remodelin acts in a progerin- and FTI-independent pathway, by targeting and inhibiting NAT10. NAT10 is a protein with histone acetylation activity and primarily identified to be involved in regulation of telomerase activity |
靶點(diǎn): |
Histone Acetyltransferase;RAAS;?HistoneAcetyltransferase |
體外研究: |
Remodelin blocks invasion and migration of HCC cells in hypoxic conditions |
體內(nèi)研究: |
Remodelin (100?mg/kg; p.o) significantly reduces the loss of subcutaneous adipose tissue that is seen in the HGPS mouse model. Animal Model: LmnaG609G/G609G mice (HGPS mice) Dosage: 100?mg/kg Administration: P.o; daily schedule from 3 weeks of age onward, until the end-point (individual weight maxima) Result: Well-tolerated by both genotypes, with no weight loss. |
參考文獻(xiàn): |
1. Balmus G, et al. Targeting of NAT10 enhances healthspan in a mouse model of human accelerated aging syndrome. Nat Commun. 2018;9(1):1700. Published 2018 Apr 27. 2. Liu H, et al. DNA damage induces N-acetyltransferase NAT10 gene expression through transcriptional activation. Mol Cell Biochem. 2007;300(1-2):249-258. 3. Ma R, et al. Up regulation of NAT10 promotes metastasis of hepatocellular carcinoma cells through epithelial-to-mesenchymal transition. Am J Transl Res. 2016;8(10):4215-4223. Published 2016 Oct 15. |
溶解性: |
soluble in DMSO |
保存條件: |
-20℃ |
配置溶液濃度參考: |
|
1mg |
5mg |
10mg |
1 mM |
2.753 ml |
13.764 ml |
27.527 ml |
5 mM |
0.551 ml |
2.753 ml |
5.505 ml |
10 mM |
0.275 ml |
1.376 ml |
2.753 ml |
50 mM |
0.055 ml |
0.275 ml |
0.551 ml |
|
注意: |
部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。 |